6.97
-0.02(-0.29%)
Currency In USD
| Previous Close | 6.99 |
| Open | 6.99 |
| Day High | 7 |
| Day Low | 6.83 |
| 52-Week High | 7.95 |
| 52-Week Low | 1.71 |
| Volume | 163,756 |
| Average Volume | 243,257 |
| Market Cap | 152.37M |
| PE | -8.3 |
| EPS | -0.84 |
| Moving Average 50 Days | 6.61 |
| Moving Average 200 Days | 4.42 |
| Change | -0.02 |
If you invested $1000 in Exagen Inc. (XGN) since IPO date, it would be worth $407.36 as of July 03, 2025 at a share price of $6.97. Whereas If you bought $1000 worth of Exagen Inc. (XGN) shares 5 years ago, it would be worth $540.31 as of July 03, 2025 at a share price of $6.97.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
GlobeNewswire Inc.
Jun 23, 2025 1:00 PM GMT
CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, is pleased to announce the appointment of Dr. Michael Mahler as Chief Scientific Officer. With an extensive backgrou
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
GlobeNewswire Inc.
May 09, 2025 8:05 PM GMT
CARLSBAD, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it has completed the sale of an additional 502,500 shares of its common stock at a public offerin
Exagen Inc. Prices Public Offering of Common Stock
GlobeNewswire Inc.
May 08, 2025 12:30 PM GMT
CARLSBAD, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3,350,000 shares of its common